PATENT CLAIM ANALYSIS

Application Number: 15743288
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "465000"]

Abstract:
The present invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing/synergizing tumor radiation therapy as well as reducing radioactive damage. The small molecular flavonoid compound can be naringenin, hesperetin, luteolin and apigenin, etc. The medication contains a small molecular flavonoid compound and a plurality of conventional pharmaceutical additives; wherein the small molecular flavonoid compound is an active ingredient.

Claim (Index 2):
The method according to  claim 1 , wherein the small molecular flavonoid compound is naringenin, hesperetin, luteolin or apigenin.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.54348
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13084408', '14308725', '15220631', '12601882', '11044638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7302758117819933
- 35 USC 102 Novelty (BERT): 0.5275102800862778
- Combined Prediction Score: 0.7099992586124217
- Mean Citation Score: 214.57032200000003
- Max Citation Score: 224.42567000000005
- Similarity Product: 112.42450967844964

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test